Results 81 to 90 of about 16,340 (253)

Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib [PDF]

, 2013
Purpose: Yttrium-90 radioembolization (RE) is a locoregional therapy option for hepatocellular carcinoma (HCC). Sorafenib is a multikinase inhibitor used in HCC that can potentially affect the efficacy of RE by altering tumor vascularity or suppressing ...
Bazylewicz, Michael, He, Aiwu Ruth, Ju, Andrew Wenhua, Kallakury, Bhaskar, Lee, Justin S., NC DOCKS at East Carolina University, Rana, Nitesh, Unger, Keith R.   +7 more
core   +2 more sources

Radiological Loco‐Regional Treatments for Cholangiocarcinoma: A Systematic Review of the Literature

Liver International, Volume 46, Issue 4, April 2026.
ABSTRACT Cholangiocarcinoma (CCA) is the second most common primary liver cancer and is being diagnosed with increasing frequency worldwide. We performed a systematic review on radiofrequency (RFA), microwave (MWA), irreversible electroporation (IRE), trans‐arterial chemoembolization (TACE) and selective internal radiation therapy (SIRT) in CCA. Thirty‐
Dimitrios Pallas, Claudia Campani, Olivier Sutter, Pierre Nahon, Nathalie Ganne‐Carrié, Olivier Seror, Jean‐Charles Nault   +6 more
wiley   +1 more source

Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla

Case Reports in Hepatology, 2014
We report a case of safe and successful yttrium-90 resin microsphere radioembolization in a patient with a long history of multiple recurrent colon cancer hepatic metastases progressing after hepatic resections, hepatic arterial chemotherapy, and ...
Vlasios S. Sotirchos, Elena N. Petre, Karen T. Brown, Lynn A. Brody, Michael I. D’Angelica, Ronald P. DeMatteo, Nancy E. Kemeny, Constantinos T. Sofocleous   +7 more
doaj   +1 more source

Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement [PDF]

, 2015
Hepatocellular carcinoma (HCC) is the most common malignancy of the liver and the third cause of cancer death worldwide. Chronic hepatitis due to HBV and HCV infection are two major risk factors for HCC worldwide.
Cuestas, María Luján, Mathet, Veronica Lidia, Oubiña, Jose Raul   +2 more
core   +1 more source

Prospective Registry and Meta‐Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real‐World Impact

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background and Aims This study aimed to evaluate the clinical efficacy of particle therapy for hepatocellular carcinoma (HCC) by integrating a prospective registry and a systematic meta‐analysis. Our findings also reflect the real‐world impact of this evidence, which contributed to the national health insurance approval of particle therapy for
Masashi Mizumoto, Kei Shibuya, Kazuki Terashima, Hiromitsu Iwata, Takashi Saito, Shingo Toyama, Takashi Ogino, Masao Murakami, Tatsuya Ohno, Yoshitaka Sato, Tetsuo Akimoto, Hiroyuki Katoh, Masaru Wakatsuki, Takahiro Waki, Norio Katoh, Fuki Koizumi, Masayuki Araya, Tsuyoshi Onoe, Masaru Takagi, Tomoaki Okimoto, Hiroyuki Ogino, Haruko Numajiri, Yoshiyuki Shioyama, Takayuki Hashimoto, Hisateru Ohba, Shoji Kubo, Kiyoshi Hasegawa, Kazushi Maruo, Hidefumi Aoyama, Hideyuki Sakurai   +29 more
wiley   +1 more source

Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization

Current Oncology, 2021
Background: Trans-arterial radioembolization (TARE) has shown promising results in treating hepatocellular carcinoma (HCC). We identified independent predictors of radiological complete response (CR) in patients with intrahepatic HCC who were treated ...
Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim   +7 more
doaj   +1 more source

Phantom validation of quantitative Y-90 PET/CT based dosimetry in liver radioembolisation [PDF]

, 2017
Background PET/CT has recently been shown to be a viable alternative to traditional post-infusion imaging methods providing good quality images of 90Y-laden microspheres after selective internal radiation therapy (SIRT).
Bagni, Oreste, Capogni, Marco, Chiaramida, Paola, De Coste, Vanessa, D’Andrea, Marco, D’Arienzo, Marco, Ferrari, Paolo, Filippi, Luca, Fischer, Alexander, Iaccarino, Giuseppe, Mariotti, Francesca, Pani, Roberto, Patterson, Nick, Paulus, Timo, Pimpinella, Maria, Spezi, Emiliano, Strigari, Lidia, Tapner, Michael   +17 more
core   +3 more sources

Dose–Response and Dose–Toxicity Relationships for Glass 90Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer

Journal of Nuclear Medicine, 2021
Visual Abstract Radioembolization based on personalized treatment planning requires established dose–response and dose–toxicity relationships. The aim of this study was to investigate dose–response and dose–toxicity relationships in patients with ...
A. A. Alsultan, C. van Roekel, M. Barentsz, M. Smits, B. Kunnen, M. Koopman, A. Braat, R. Bruijnen, B. de Keizer, M. Lam   +9 more
semanticscholar   +1 more source

Transarterial Infusion of Pembrolizumab Plus TACE for Liver Metastases of Melanoma

Cancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Melanoma hepatic metastases demonstrate limited responsiveness to conventional systemic immune checkpoint blockade therapy, primarily attributed to the hepatic microenvironment's immunosuppressive characteristics. To our knowledge, this is the first reported case describing selective hepatic arterial infusion of pembrolizumab ...
Shahram Akhlaghpoor, Hamidreza Rouientan
wiley   +1 more source

MVP-Assisted Temporary Vascular Occlusion during ⁹⁰Y Radioembolization: A Case Report

Journal of Clinical Interventional Radiology ISVIR
Yttrium-90 radioembolization is an effective treatment for liver cancers. However, deposition of radioactive microspheres in nondiseased liver can result in parenchymal injury.
John J. Park, Franz Edward Boas, Federico Pedersoli   +2 more
doaj   +1 more source